Publications by authors named "Chaoling Wan"

Claim this Profile
V
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysis.
Yuan-Hong Huang, Fang-Tong Liu, Chao-Ling Wan, Zi-Jin Wang, Yu-Qing Liu, Miao Wang, Zi-Hao Wang

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial.
Han-Yu Cao, Hao Zhang, Yang Zhang, Xiao-Hui Hu, Li Yang, Rui-Juan Wang, Chao-Ling Wan

Lancet Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canertinib as an FLT3 Inhibitor with Potent Activity Against FLT3-Mutated and AC220-Resistant Acute Myeloid Leukemia.
Hongfeng Pang, Chaoling Wan, Maofeng Zhang, Shuaishuai Ge, Yuanhong Huang

J Vis Exp· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCT.
Ya-Xue Wu, Chao-Ling Wan, Kai-Wen Tan, Yang Zhang, Yan-Ming Zhang, Ying Wang

Clin Epigenetics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A Study of Flow Sorting Lymphocyte Subsets to Detect Epstein-Barr Virus Reactivation in Patients with Hematological Malignancies].
Hui-Ying Li, Shen-Hao Liu, Fang-Tong Liu, Kai-Wen Tan, Zi-Hao Wang, Chao-Ling Wan

Zhongguo Shi Yan Xue Ye Xue Za Zhi· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.
Meng-Miao Wang, Si-Man Huang, Yuan-Hong Huang, Jian Zhang, Hui-Ying Li, Chao-Ling Wan, Miao Wang, Zi-Hao Wang

Bone Marrow Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.
Fang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, Han-Yu Cao, Xiao-Yu Lyu, Zi-Hao Wang

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution from B-cell acute lymphoblastic leukemia with BCR::ABL1 multilineage involvement to acute myeloid leukemia after multiple anti-CD19 chimeric antigen receptor T-cell therapy.
Mei-Jing Liu, Lan Dai, Li Yao, Kai-Wen Tan, Han-Yu Cao, Chao-Ling Wan

Haematologica· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Miao Wang, Zi-Hao Wang

Blood Cancer J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study.
Chao-Ling Wan, Yuan-Hong Huang, Si-Man Huang, Yan-Li Xu, Kai-Wen Tan

Leuk Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study.
Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.
Si-Man Huang, Chao-Ling Wan, Han-Yu Cao, Yan-Yan Li, Chong-Sheng Qian

Clin Case Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.
Kai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, Man Wang, Hong-Jie Shen, Chao-Ling Wan

Ann Hematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Yuan-Hong Huang, Chao-Ling Wan, Hai-Ping Dai, Sheng-Li Xue

Ann Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy.
Shuai-Shuai Ge, Qiao-Cheng Qiu, Hai-Ping Dai, Xiang-Dong Shen, Tian-Mei Wu, Chao-Ling Wan

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, Hai-Xia Zhou, Mei-Jing Liu

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltration.
Han-Yu Cao, Hui Chen, Song-Bai Liu, Wen-Jie Gong, Chong-Sheng Qian, Chao-Ling Wan

Front Immunol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metagenomic next-generation sequencing performed on blood samples for the early recognition of severe Pneumocystis pneumonia in critical hematological patients.
Xiang-Dong Shen, Xu-Dong Pan, Sen-Sen Shi, Ting Xu, Sheng-Li Xue, Jun Wang, Chao-Ling Wan

Medicine (Baltimore)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.
Han-Yu Cao, Chao-Ling Wan, Sheng-Li Xue

Ann Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome-positive acute myeloid leukemia: A case report.
Si-Man Huang, Tao Tao, Chao-Ling Wan, Tian-Mei Wu, Han-Yu Cao, Bin-Ru Wang

Clin Case Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency of anti-VEGF therapy in central nervous system AML relapse: A case report and literature review.
Han-Yu Cao, Tao Tao, Xiang-Dong Shen, Lian Bai, Chao-Ling Wan

Clin Case Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Venetoclax and Midostaurin Efficiently Suppressed Relapsed t(8;21)Acute Myeloid Leukemia With Mutant KIT After Failure of Venetoclax Plus Azacitidine Treatment.
Zheng Li, Jun Wang, Shuai-Shuai Ge, Qiao-Cheng Qiu, Jia-Hui Du, Chao-Ling Wan, Bin-Ru Wang

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series.
Chao-Ling Wan, Jing-Ying Zou, Man Qiao, Jia Yin, Xiang-Dong Shen

Leuk Lymphoma· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports.
Bin-Ru Wang, Chao-Ling Wan, Song-Bai Liu, Qiao-Cheng Qiu, Tian-Mei Wu, Jun Wang

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia.
Jia Yin, Chao-Ling Wan, Ling Zhang, Hao Zhang, Lian Bai

Front Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis